American Journal of Medical Genetics Part A · 2018 · 18 citations · 14 references
MedicineGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsMolecular PathologyConnective Tissue DiseasesDysplasiaGenetic DisordersLymphedema PathophysiologyAutosomal Recessive InheritanceBiallelic Gene DisruptionExtracellular Matrix Gene MutationsMutationNeurocognitive ImpairmentVascular Endothelial Growth Factor-c Signaling
Hennekam lymphangiectasia-lymphedema syndrome (HKLLS) is a genetically heterogeneous lymphatic dysplasia with characteristic of facial dysmorphism, neurocognitive impairments, and abnormalities of the pericardium, intestinal tract, and extremities. It is an autosomal recessive condition caused by biallelic mutations in CCBE1 (collagen- and calcium-binding epidermal growth factor domain-containing protein 1) (HKLLS1; OMIM 235510) or FAT4 (HKLLS2; OMIM 616006). CCBE1 acts via ADAMTS3 (a disintegrin and metalloprotease with thrombospondin motifs-3 protease) to enhance vascular endothelial growth factor C signaling. There is report of one family supporting mutations in ADAMTS3 as causative for the phenotype labeled as HKLLS3. Here, we report an additional case of HKLLS that appears to be associated with homozygous nonsense mutation of ADAMTS3.
14
Proteolytic processing regulates receptor specificity and activity of VEGF‐C
Vladimir Joukov, Tarja Sorsa, Vijay Kumar et al. · The EMBO Journal · 1997 · 772 citations · Full text
Kelly D. Farwell, Layla Shahmirzadi, Dima El‐Khechen et al. · Genetics in Medicine · 2014 · 468 citations · Full text
Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans
Mariëlle Alders, Benjamin M. Hogan, Evisa Gjini et al. · Nature Genetics · 2009 · 321 citations
Michael Jeltsch, Sawan Kumar Jha, Denis Tvorogov et al. · Circulation · 2014 · 239 citations